Cargando…
Achieving the unimaginable: Health equity in haemophilia
Historically, treatment based on the availability of clotting factor replacement has resulted in an arcane guideline for the correction of factor deficiencies in people with haemophilia (PwH). While all other disease entities seek to restore function to a normal level, PwH are restricted to factor n...
Autores principales: | Skinner, Mark W., Nugent, Diane, Wilton, Pam, O’Mahony, Brian, Dolan, Gerry, O’Hara, Jamie, Berntorp, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891319/ https://www.ncbi.nlm.nih.gov/pubmed/31724316 http://dx.doi.org/10.1111/hae.13862 |
Ejemplares similares
-
Evidence of a disability paradox in patient‐reported outcomes in haemophilia
por: O’Hara, Jamie, et al.
Publicado: (2021) -
Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment
por: Witkop, Michelle, et al.
Publicado: (2021) -
Association of factor expression levels with annual bleeding rate in people with haemophilia B
por: Burke, Tom, et al.
Publicado: (2022) -
Journey to the Unimaginably Strange
por: Mann, Chris
Publicado: (2022) -
Journey to the Unimaginably Small
por: Mann, Chris
Publicado: (2011)